Investigation of Gene Polymorphisms of Vaspin, Visfatin and Chemerin in Diabetic Obese and Non-Diabetic Obese Patients
| Autor: | Şermin Durak, Zeliha Doğan, Umit Zeybek, Arezoo Gheybi, Osman Fazlıoğulları, Faruk Çelik, Nur Gökçe Çetiner, Büşra Aksoyer, Cem Başaran, Kaan Oran |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
biology business.industry medicine.disease Obesity Diabetes Obesity Vaspin Chemerin Visfatin Polymorphism Endocrinology Health Care Sciences and Services Polymorphism (computer science) Diabetes mellitus Internal medicine biology.protein Medicine Chemerin Sağlık Bilimleri ve Hizmetleri business Gene Non diabetic |
| Zdroj: | Volume: 5, Issue: 2 33-38 Sağlık Hizmetleri ve Eğitimi Dergisi |
| ISSN: | 2636-8285 |
| Popis: | Diabetes mellitus and obesity are very similar in terms of pathogenesis and pathophysiology. Most obese patients have adipose tissue dysfunction caused by genetic and environmental factors. Adipose tissue is the source of adipokines secreted from adipocytes. Vaspin, Visfatin and Chemerin are adipokines discovered in recent years. The study consists of 43 non-diabetic obese and 51 diabetic obese individuals. The PCR-RFLP method and agarose gel electrophoresis techniques were used to detect gene polymorphisms of Chemerin rs17173608, Vaspin rs2236242 and Visfatin rs2110385 from DNA samples. In our study, when diabetic obese and non-diabetic obese patient groups were examined in terms of Vaspin gene polymorphism, statistically significant results were obtained (22% → 7%, p=0.048, respectively). The distribution of Chemerin or Visfatin gene variants were not different in study groups (p>0.05). Our results indicate that Chemerin rs17173608 and Visfatin rs2110385 gene polymorphisms were not risk factors for development of diabetes in obese individuals, however, Vaspin rs2236242 gene polymorphism may be a contributory risk of development of diabetes in obese individuals. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|